Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Détails bibliographiques
Auteur principal:	Rahman, Tasnim
Autres auteurs:	Azam, Faruque
Format:	Thèse
Langue:	English
Publié:	Brac University 2024
Sujets:	Efficacy endpoint Clinical trial Treatment size Lung cancer Lung > Cancer > Treatment
Accès en ligne:	http://hdl.handle.net/10361/22174

Documents similaires

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
par: Paul, Pulock
Publié: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Flora, Sanzida Alam
Publié: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
par: Hoque, Ismoth Ara
Publié: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Karim, Samia Binte
Publié: (2024)

Potential of liposomes for the treatment of lung cancer- a review
par: Mim, Shanzida
Publié: (2023)

A review on targeted therapies for lung cancer
par: Ashraf, Anushey
Publié: (2023)

A review on recent advances in drugs for lung cancer treatment
par: Noor, Fouzia
Publié: (2024)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
par: Zangmo, Thinley
Publié: (2024)

Molecules associated with the development of lung cancer
par: Rahman, Adree, et autres
Publié: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
par: Jeba, Joynob
Publié: (2017)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
par: Tania, Umme
Publié: (2023)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
par: Shobnam, Sohana
Publié: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
par: Razna, Amrin Islam
Publié: (2019)

Immunotherapy in the Management of Lung Cancer
par: Tasnim, Humayra
Publié: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
par: Pial, Sazia Afrin
Publié: (2018)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
par: Das, Reshita
Publié: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
par: Bristy, Israt Zerin
Publié: (2021)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
par: Shabnam, Musharrat
Publié: (2018)

Current practice and approaches of immunotherapy in Cancer treatment
par: Khondokar, Faiza
Publié: (2022)

Biosimilar in lymphoma treatment
par: Tanisha, Mehrin Haque
Publié: (2021)

Lung cancer detection and classification using machine learning
par: Arefin, Mahbubul, et autres
Publié: (2023)

Recent advancement on breast cancer detection and treatment
par: Rahman, Sanjida
Publié: (2023)

Targeting BRAFV600E in the treatment of CRC
par: Roja, Mashwiyat Samrin
Publié: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
par: Jahan, Nusrat
Publié: (2024)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
par: Mukti, Roushney Fatima, et autres
Publié: (2016)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
par: Nandy, Aditi
Publié: (2022)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
par: Muntaha, Habibatul
Publié: (2023)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
par: Rahman, Qazi Ashrafur
Publié: (2018)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
par: Hossain, Safa Binte
Publié: (2019)

ক্যান্সার : মৃত্যু অবধারিত নয় /
par: করীম, আবুল বাশার মোহাম্মদ ফজলুল

Dendritic cell vaccine for the treatment of cancer
par: Haque, Tanzila
Publié: (2023)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
par: Shaikat, Mahdi Mubin
Publié: (2023)

A comprehensive review on drug repurposing in cancer treatment
par: Sarkar, Onusree
Publié: (2024)

Stem cells as therapeutic carrier in cancer treatment
par: Anika, Mysha Yeasmin
Publié: (2022)

A review on non-polyphenolic and terpenoid phytoconstituents with antioxidant and cytotoxic potential
par: Ahmed, Kazi Zeba
Publié: (2021)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
par: Hasan, Sakib
Publié: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
par: Nahar, Kamrun
Publié: (2023)

Natural products and their combinatory effects in breast cancer treatment
par: Siddique, Md. Ayman
Publié: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
par: Alam, Kazi Tasnuva
Publié: (2022)

A review on artemisinin based combination therapy for the treatment of Malaria
par: Chowdhury, Amina Ferdous
Publié: (2020)